Back to Authors

Waldron-Lynch, M.

Mayo Clinic

MorphoSys US, Inc., Boston, United States of America

Citations 1

PB2110: PHARMACOKINETICS AND PHARMACODYNAMICS IN FIRST-MIND: A PHASE IB, OPEN-LABEL, RANDOMIZED STUDY OF TAFASITAMAB ± LENALIDOMIDE + R-CHOP IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA
Belada, D., Kopeckova, K., Burgués, Juan Miguel Bergua, Stevens, D., Nowakowski, G. S., Waldron-Lynch, M., Hadar, N., Weirather, J., Lässig, C., Blair, D., Dreyling, M., Kopečková, K., Waldron-Lynch, M., Dreyling, Martin

HemaSphere | June 24, 2022 | Volume: 6 | Issue: No issue available | Pages: 1981-1982

10.1097/01.hs9.0000851272.68157.fc Get It